ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancer

Mendeley Data2026-04-18 收录

下载链接：

https://data.mendeley.com/datasets/dd6bvtrv9b

下载链接

链接失效反馈

官方服务：

资源简介：

We developed long-term resistant pre-clinical models to two complementary drugs: adavosertib (ADA) and paclitaxel (PTX). Through multiomics functional profiling we identified distinct transcriptomic and morphological changes in the ovarian cancer resistant models. - seurat_counts.csv.gz: raw counts for sc-data - seurat_metadata.csv.gz: metadata for sc-data - CellPainting_raw_data.zip: Cell Painting features extracted with CellProfiler - SourceData_FigureS3.zip: Source data for figure S3 - SourceData_FigureS4.zip: Source data for figure S4 - SourceData_FigureS6.zip: Source data for figure S6

创建时间：

2026-01-14